Spillane, Andrew

The University of Sydney · Royal North Shore Hospital · Melanoma Institute Australia

25 papers on CoChatORCID 0000-0002-8354-434X

Most cited papers

Verified
18-months relapse-free survival (RFS) and biomarker analyses of OpACIN-neo: A study to identify the optimal dosing schedule of neoadjuvant (neoadj) ipilimumab (IPI) + nivolumab (NIVO) in stage III melanoma
Rozeman, E. A., Menzies, A. M., Krijgsman, O., Hoefsmit, E. P., van de Wiel, B. A., Sikorska, K., Van, T. M., Eriksson, H., Bierman, C., Gonzalez, M., et al. (2019) · Annals of Oncology
Cancer Immunotherapy and BiomarkersCutaneous Melanoma Detection and Management
Cited by 20

Go further with a free account

Verify every reference, keep papers in a library, and ask questions across them.

Sign up - it is free